1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | Andrew Craig, Martin Forster, Samra Turajlic, Sergio A Quezada, Katy Newton, Karl Peggs, Fong Chan, Karen Matthews, Theres Oakes, Gareth Wilson, Elizabeth Larose Cadieux, Max Salm, Hugh O’Brien |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
Similar Items
437 Optimised achilles VELOSTM process 2b manufacturing platform generates a significant dose boost of reactive CD8 and CD4 clonal neoantigen-reactive T cells for the treatment of solid cancer
by: Sergio A Quezada, et al.
Published: (2023-11-01)
by: Sergio A Quezada, et al.
Published: (2023-11-01)
The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
by: Shefali Mehra, et al.
Published: (2024-01-01)
by: Shefali Mehra, et al.
Published: (2024-01-01)
Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients
by: Peng Zhao, et al.
Published: (2026-06-01)
by: Peng Zhao, et al.
Published: (2026-06-01)
Inverse relationship between neoantigen clonality and T-cell activity reveals distinct immune phenotypes in HNSCC
by: Babak Saravi, et al.
Published: (2026-06-01)
by: Babak Saravi, et al.
Published: (2026-06-01)
Compromised function in the Nav1.2 Dravet syndrome mutation R1312T
by: Christoph Lossin, et al.
Published: (2012-09-01)
by: Christoph Lossin, et al.
Published: (2012-09-01)
Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product
by: David Willoughby, et al.
Published: (2025-03-01)
by: David Willoughby, et al.
Published: (2025-03-01)
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
by: Stefani Spranger, et al.
Published: (2024-11-01)
by: Stefani Spranger, et al.
Published: (2024-11-01)
Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-06-01)
by: Yury Patskovsky, et al.
Published: (2023-06-01)
P1312: CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Yue Jin, et al.
Published: (2023-08-01)
by: Yue Jin, et al.
Published: (2023-08-01)
The Impact of military action of Nomads Settling Project on the Lorestan Social Life (1302-1312)
by: مهدی صلاح, et al.
Published: (2017-01-01)
by: مهدی صلاح, et al.
Published: (2017-01-01)
Cancer neoantigens and immunogenicity: mutation position matters
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)
Handel miedzią węgierską a restytucja rządów Władysława Łokietka w Polsce (1304-1312)
by: Tomasz Jasiiński
Published: (2019-04-01)
by: Tomasz Jasiiński
Published: (2019-04-01)
1461 Induction of clonal expansion of tumor-reactive T cells and effective tumor suppression by neoantigens predicted from the ‘VACINUS‘ platform
by: Sang Hoon Kim, et al.
Published: (2023-11-01)
by: Sang Hoon Kim, et al.
Published: (2023-11-01)
Isolation, characterization and complete genome analysis of P1312, a thermostable bacteriophage that infects Thermobifida fusca
by: Jatuporn eCheepudom, et al.
Published: (2015-09-01)
by: Jatuporn eCheepudom, et al.
Published: (2015-09-01)
MHC2-SCALE enhances identification of immunogenic neoantigens
by: Joshua G. Gober, et al.
Published: (2025-04-01)
by: Joshua G. Gober, et al.
Published: (2025-04-01)
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-07-01)
by: Yury Patskovsky, et al.
Published: (2023-07-01)
3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
by: Jason Devlin, et al.
Published: (2019-03-01)
by: Jason Devlin, et al.
Published: (2019-03-01)
Pre‐existing heterologous T‐cell immunity and neoantigen immunogenicity
by: Qibin Leng, et al.
Published: (2020-01-01)
by: Qibin Leng, et al.
Published: (2020-01-01)
Lymphoma neoantigens
by: Joshua E. Elias
Published: (2018-06-01)
by: Joshua E. Elias
Published: (2018-06-01)
929 Mutual interactions between neoantigen-specific CD8+ T cell responses facilitate immune evasion in sub-clonal tumors
by: Stefani Spranger, et al.
Published: (2023-11-01)
by: Stefani Spranger, et al.
Published: (2023-11-01)
CCSDS 131.2-B-1 Serial Concatenated Convolutional Turbo Decoder Architecture for Efficient FPGA Implementation
by: Miguel Angel Perez Naranjo, et al.
Published: (2023-01-01)
by: Miguel Angel Perez Naranjo, et al.
Published: (2023-01-01)
Identification of immunogenic neoantigens from intron retention in colorectal cancer
by: Thamizhanban Manoharan, et al.
Published: (2026-03-01)
by: Thamizhanban Manoharan, et al.
Published: (2026-03-01)
Homologous recombination-DNA damage response defects increase TMB and neoantigen load, but not effector T cell density and clonal diversity in pancreatic cancer
by: Mengyue Lei, et al.
Published: (2025-06-01)
by: Mengyue Lei, et al.
Published: (2025-06-01)
Autoimmunity: the neoantigen hypothesis
by: Tomas Mustelin, et al.
Published: (2024-06-01)
by: Tomas Mustelin, et al.
Published: (2024-06-01)
M. Nuyttens, Krijgers voor God. De orde van de tempeliers in de Lage Landen (1120-1312)
by: Jan Hosten
Published: (2008-01-01)
by: Jan Hosten
Published: (2008-01-01)
Identification of a Copy Number Variation on Chromosome 20q13.12 Associated with Osteoporotic Fractures in the Korean Population
by: Tae-Joon Park, et al.
Published: (2016-12-01)
by: Tae-Joon Park, et al.
Published: (2016-12-01)
Tensiones nobiliarias y gobierno municipal en Córdoba durante la minoría de Alfonso XI (1312-1325)
by: Manuel García Fernández
Published: (1998-12-01)
by: Manuel García Fernández
Published: (1998-12-01)
Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis
by: Guadalupe Nibeyro, et al.
Published: (2023-07-01)
by: Guadalupe Nibeyro, et al.
Published: (2023-07-01)
WCN24-1312 Late-Onset Rhupus? Lupus Nephritis Associated with Rheumatoid Arthritis in a 67-Year-Old Woman
by: Francisco Gabriel Salgado González, et al.
Published: (2024-04-01)
by: Francisco Gabriel Salgado González, et al.
Published: (2024-04-01)
On the Frequency Carrier Offset and Symbol Timing Estimation for CCSDS 131.2-B-1 High Data-Rate Telemetry Receivers
by: Matteo Bertolucci, et al.
Published: (2021-04-01)
by: Matteo Bertolucci, et al.
Published: (2021-04-01)
Shared neoantigens for cancer immunotherapy
by: Anastasia Goloudina, et al.
Published: (2025-06-01)
by: Anastasia Goloudina, et al.
Published: (2025-06-01)
Tumor neoantigens and tumor immunotherapies
by: Wang Jiani, et al.
Published: (2024-04-01)
by: Wang Jiani, et al.
Published: (2024-04-01)
Editorial: The Clinical Application of Neoantigens
by: Jian-Guo Zhou, et al.
Published: (2022-03-01)
by: Jian-Guo Zhou, et al.
Published: (2022-03-01)
Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
by: Weijiang Liu, et al.
Published: (2025-03-01)
by: Weijiang Liu, et al.
Published: (2025-03-01)
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
by: Weijing Cai, et al.
Published: (2018-08-01)
by: Weijing Cai, et al.
Published: (2018-08-01)
Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification
by: Lena Pfitzer, et al.
Published: (2025-08-01)
by: Lena Pfitzer, et al.
Published: (2025-08-01)
Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
by: Roy A. Mariuzza, et al.
Published: (2023-11-01)
by: Roy A. Mariuzza, et al.
Published: (2023-11-01)
Angiogenic potential of clonal populations of human mesenchymal stem cells
by: Scott J, et al.
Published: (2012-07-01)
by: Scott J, et al.
Published: (2012-07-01)
P852: NEOANTIGENS PREDICTED BY THE GNE NEOANTIGEN PIPELINE IN PATIENTS DIAGNOSED WITH DE NOVO MULTIPLE MYELOMA
by: Y. Jiang, et al.
Published: (2022-06-01)
by: Y. Jiang, et al.
Published: (2022-06-01)
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)
by: Yanwei Shen, et al.
Published: (2022-08-01)
Similar Items
-
437 Optimised achilles VELOSTM process 2b manufacturing platform generates a significant dose boost of reactive CD8 and CD4 clonal neoantigen-reactive T cells for the treatment of solid cancer
by: Sergio A Quezada, et al.
Published: (2023-11-01) -
The clonal hydra: neoantigen-specific T-cell response in germ cell tumors
by: Shefali Mehra, et al.
Published: (2024-01-01) -
Profiling immunogenic neoantigen peptides elicited by personalized neoantigen vaccine in cancer patients
by: Peng Zhao, et al.
Published: (2026-06-01) -
Inverse relationship between neoantigen clonality and T-cell activity reveals distinct immune phenotypes in HNSCC
by: Babak Saravi, et al.
Published: (2026-06-01) -
Compromised function in the Nav1.2 Dravet syndrome mutation R1312T
by: Christoph Lossin, et al.
Published: (2012-09-01)
